NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: MD Anderson

6/8/2016

More study details and costs warranted in release on immunotherapy for advanced bladder cancer

1 4/25/2016

Harms, costs and clear benefits omitted from release on anal cancer drug trial

10/3/2015

More context would be helpful on kidney cancer “breakthrough”

8/26/2015

Beta-blockers “prolong survival” in ovarian cancer? Not so fast